Research on Intraoperative Hypothermia Risk Prediction Model and Temperature Management Strategy for Elderly Patients During Surgery Based on Dynamic Incremental Training
1 other identifier
interventional
1,323
1 country
1
Brief Summary
With the support of partial dual temperature monitoring (comparing the specific difference between standardized axillary temperature monitoring and esophageal temperature), this trial is divided into the following three parts:
- 1.Multi center observational study: Establish and validate a dynamic incremental training intraoperative hypothermia prediction model - Intelligent Care for the Elderly (ICE) - Intraoperative hypothermia warning system, and provide ICE Offline for use by healthcare professionals and ICE Online for further model updates when needed for clinical or research purposes.
- 2.Multi center non randomized controlled clinical trial: Conduct a multi center stratified temperature management clinical trial based on ICE Offline after dynamic incremental training to verify the clinical and economic benefits of the model and active warming.
- 3.Pre and post comparative study: Collect data before ICE application and compare it with data after ICE promotion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 31, 2024
CompletedFirst Posted
Study publicly available on registry
November 6, 2024
CompletedStudy Start
First participant enrolled
March 11, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 14, 2026
CompletedJanuary 16, 2026
January 1, 2026
9 months
October 31, 2024
January 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Intraoperative hypothermia
Intraoperative hypothermia, defined as a core temperature below 36 °C
Up to 24 hours, from the time of entry into the operating room to the time of exit from the operating room.
Secondary Outcomes (16)
The specificity and sensitivity of the model
1 year
Physical sensation
Perioperative period
Total volume of intraoperative blood loss
Intraoperative
Postoperative shivering
Up to 60 minutes
Postoperative coagulation index
Within 24 hours after operation
- +11 more secondary outcomes
Study Arms (4)
Intraoperative hypothermia low risk group
EXPERIMENTALPatients included this group are determined by prediction model. Operating room environment temperature was set at not less than 21°C, with a relative humidity of 50% to 60%. Patients are covered from neck to feet with a cotton blanket and the area to be disinfected and operated on is uncovered after induction of anesthesia. All patients will be administered intravenous fluid warmers and irrigation fluid prewarming (37℃\~43℃).
Intraoperative hypothermia high risk group
EXPERIMENTALPatients included this group are determined by prediction model. In addition to the measures taken in intraoperative hypothermia low risk group, an inflatable warming system, including a forced air warming system and forced air warming blanket, is employed for prewarming before anesthesia initiation and for maintaining body temperature throughout the operation. During the surgery, the insulation blanket will be applied to non surgical areas, and the host temperature will be adjusted to 38 ℃ for warming. If the temperature of the patient is lower than 36 ℃, the temperature of the system can be adjusted to 43 ℃; if the temperature of the patient is higher than 37 ℃, the temperature of the system can be adjusted to 32 ℃. After the patient's temperature is normal, it can be adjusted back to 38 ℃.
Model optimization group
OTHEROnly observe the patient's baseline, intraoperative hypothermia, postoperative complications, and other indicators, and collect data through the electronic Data Capture System to optimize existing intraoperative hypothermia prediction model. The estimated sample size is 600 cases by the incremental learning curve calculating.
Group of model benefit evaluation
NO INTERVENTIONData of this group is medical records before the application of the intraoperative hypothermia prediction model, which will be collected from the electronic medical record system.
Interventions
Inflatable warming system, including a forced air warming system (IOB, WU505) and forced air warming blanket (IOB-001, IOB-006, IOB-011), is employed for prewarming before anesthesia initiation and for maintaining body temperature throughout the operation. During the surgery, the insulation blanket will be applied to non surgical areas, and the host temperature will be adjusted to 38 ℃ for warming. If the temperature of the patient is lower than 36 ℃, the temperature of the system can be adjusted to 43 ℃; if the temperature of the patient is higher than 37 ℃, the temperature of the system can be adjusted to 32 ℃. After the patient\'s temperature is normal, it can be adjusted back to 38 ℃.
According to the Intelligent Care For The Elderly (ICE, an optimized model based on the existing prediction model of our research group after dynamic incremental training), patients are divided into intraoperative hypothermia lowrisk group and intraoperative hypothermia high risk group.
Previous studies have shown that the difference and standard deviation between esophageal temperature and axillary temperature are core 0.05 ℃ and 0.26 ℃, respectively. In light of 10% dropout rate, a integer sample size of 400 achieves 95% power to detect a mean of paired differences of 0.05 with an estimated standard deviation of paired differences of 0.26 and with a significance level (alpha) of 0.05 using a two-sided paired t-test. So 400 patients in the Model optimization group need to undergo core temperature (esophageal temperature or nasopharyngeal temperature).
As a intraoperative core temperature reference (measure every 15 minutes) for patients without esophageal temperature or nasopharyngeal temperature monitoring.
Eligibility Criteria
You may qualify if:
- Elderly patients (aged 60 and above) undergoing non cardiac elective surgery under general anesthesia;
- minutes ≤ Estimated surgical duration ≤ 240 minutes ;
- Normal preoperative bleeding and clotting time
- American society of Aneshesiologists physical status classification system:Ⅰ~Ⅳ
You may not qualify if:
- Mental illness
- Cirrhosis
- Existence or potential central hyperthermia
- Metabolic thermoregulatory abnormalities
- History of malignant hyperthermia or family history
- Extensive skin burns or injuries
- Seriously infect
- Long term use of nonsteroidal anti-inflammatory drugs
- Expected difficult airway
- Researchers believe that individuals who are not suitable to participate in clinical trial
- Refusal to sign informed consent form
- Withdraw informed consent form
- Severe bleeding or shock during perioperative period.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, 400010, China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director
Study Record Dates
First Submitted
October 31, 2024
First Posted
November 6, 2024
Study Start
March 11, 2025
Primary Completion
December 15, 2025
Study Completion
January 14, 2026
Last Updated
January 16, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR
Data Data available: Yes Data types: Identified participant data How to access data: atpcr7@yeah.net When available: Within 5years after this trial Supporting Documents Document types: None Additional Information Who can access the data: Researchers whose proposed use of the data have been approved by Leader Sponsor and Principal Investigator of this trial. Types of analyses: To be discussed with the steering committee. Mechanisms of data availability: With investigator support after approval signed data access agreement. Any additional restrictions: None